E Fund Management’s Immunogen Inc IMGN Stock Holding History

E Fund Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16,443	Closed	-$488K	–	386
2023 Q4	$488K	Sell	16,443 -12,682	-44%	-$253K	0.03%	172
2023 Q3	$462K	Buy	29,125 +10,992	+61%	+$183K	0.04%	134
2023 Q2	$342K	Sell	18,133 -59,530	-77%	-$703K	0.03%	200
2023 Q1	$298K	Buy	77,663 +5,958	+8%	+$25.4K	0.02%	226
2022 Q4	$356K	Buy	71,705 +6,577	+10%	+$35.7K	0.03%	203
2022 Q3	$311K	Sell	65,128 -20,636	-24%	-$109K	0.03%	232
2022 Q2	$386K	Buy	85,764 +42,978	+100%	+$187K	0.04%	195
2022 Q1	$204K	Buy	42,786 +29,338	+218%	+$162K	0.01%	294
2021 Q4	$100K	Sell	13,448 -3,350	-20%	-$20.8K	﹤0.01%	287
2021 Q3	$95K	Buy	+16,798	New	+$97.1K	﹤0.01%	260
2021 Q1	$127K	Buy	+15,645	New	+$128K	0.01%	231

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

E Fund Management's IMGN Position: Q1 2024 in Review

E Fund Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 16,443 shares — an estimated $488K sold.

E Fund Management first reported a position in IMGN in Q1 2021 and held it in 11 quarters. The position peaked at $488K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

E Fund Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
E Fund Management sold 16,443 Immunogen Inc shares in Q1 2024, an estimated $488K.
E Fund Management first reported a position in Immunogen Inc in Q1 2021 and held it in 11 quarters.
E Fund Management's Immunogen Inc position peaked at $488K in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on E Fund Management's 13F filing for Q1 2024, filed 13 May 2024.